SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-009006
Filing Date
2022-05-10
Accepted
2022-05-10 16:29:32
Documents
70
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ccxi-20220331.htm   iXBRL 10-Q 2139973
2 EX-10.1 ccxi-ex10_1.htm EX-10.1 28626
3 EX-31.1 ccxi-ex31_1.htm EX-31.1 15040
4 EX-31.2 ccxi-ex31_2.htm EX-31.2 14886
5 EX-32.1 ccxi-ex32_1.htm EX-32.1 10691
6 EX-32.2 ccxi-ex32_2.htm EX-32.2 10716
  Complete submission text file 0000950170-22-009006.txt   8812836

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ccxi-20220331_cal.xml EX-101.CAL 55900
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ccxi-20220331_pre.xml EX-101.PRE 312692
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ccxi-20220331_lab.xml EX-101.LAB 440433
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ccxi-20220331_def.xml EX-101.DEF 150202
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ccxi-20220331.xsd EX-101.SCH 54741
64 EXTRACTED XBRL INSTANCE DOCUMENT ccxi-20220331_htm.xml XML 1916437
Mailing Address 835 INDUSTRIAL ROAD SUITE 600 SAN CARLOS CA 94070
Business Address 835 INDUSTRIAL ROAD SUITE 600 SAN CARLOS CA 94070 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35420 | Film No.: 22910174
SIC: 2834 Pharmaceutical Preparations